Neko Health
Neko Health raises $260M Series A at $1.7B valuation
Quick Facts
Neko Health: Series A Funding Round
Neko Health has successfully raised $260M in Series A funding, reaching a valuation of $1.7B.
Company Overview
Preventative health screening platform
Funding Details
The Series A round was led by General Catalyst, with participation from Lakestar.
Company Information
- Headquarters: Stockholm, Sweden
- Founded: 2018
- Employees: 300+
- Category: HealthTech
Investment
Neko Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- General Catalyst: Verified investor in Series A
- Lakestar: Verified investor in Series A
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
